Condition

Progesterone Resistance clinical trials and research

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Using GnRHa and Letrozole for Obese Women with Progestin-Insensitive Endometrial Cancer

  This study is testing a new treatment combining GnRH antagonist and letrozole to see if it helps obese women with a specific type of endometrial cancer that hasn't responded to standard therapy.

  Recruiting at 2 sites Phase 2/3 Fudan University · Shanghai, Shanghai Municipality and 1 other locations · NCT06379113

• Combining GnRHa and Letrozole for Non-obese Patients with Endometrial Cancer

  This study is testing if a combination of GnRHa and letrozole can help non-obese patients with early-stage endometrial cancer keep their fertility when standard treatments haven't worked.

  Recruiting at 2 sites Phase 2/3 Fudan University · Shanghai, Shanghai Municipality and 1 other locations · NCT05316935

Related topics

Quick answers

How many Progesterone Resistance clinical trials are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2/3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →